Metastat (PVSO) Return on Equity ROE from the fourth quarter 2018 to fourth quarter 2014 and annually, average high and low, overall ranking from Feb 28 2018 to Feb 28 2014 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Metastat, Inc.  (PVSO)

Metastat's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Metastat in the fourth quarter 2018?
Due to the lack of equity, it was not possible to calculate Metastat, Inc.'s return on equity (ROE) in its fourth quarter 2018

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Feb 28 2018)
IV. Quarter		 (Nov 30 2014)
III. Quarter		 (Aug 31 2014)
II. Quarter		 (May 31 2014)
I. Quarter		 (Feb 28 2014)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -8 -8 -8 -5 -5
Return On Equity (TTM) - - - - -
PVSO's Total Ranking # # # # #
Equity (TTM) in Millions -2 0 1 -3 -2
Seq. Equity Change - -79.11 % - - -
Seq. Net Income Change - - - - -

Back to PVSO Management Effectiveness >> PVSO's 5 Years Annual ROE >> Compare PVSO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





PVSO Annual Return On Equity (Feb 28 2018)
2018		 (Feb 28 2014)
2014		 (Feb 28 2013)
2013		 (Feb 29 2012)
2012		 (Feb 28 2011)
2011
Total Equity in Millions -2 -2 0 2 0
Y / Y Equity Change - - -93.08 % 674.29 % -
Net Income in Millions -3 -5 -3 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - -1858.67 % -19.95 % 143.5 %

Back to PVSO Management Effectiveness >> PVSO's 5 Years Annual ROE >> Compare PVSO ROE to its Competitors




Annual Roe Comment
In 2018 ROE improved to 143.5 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PVSO's' Return on Equity at Yahoo Finance
PVSO's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PVSO's Competitors
Subscribers only: Roe for Metastat's Suppliers
Subscribers only: Return On Equity for PVSO's Customers




Companies with similar Return On Equity at Feb 28 2018, within Healthcare Sector ROE
Merrimack Pharmaceuticals Inc  491.00 %
Fonar Corporation  459.79 %
Health right Discoveries Inc   388.16 %
Zynex inc   356.86 %
Palatin Technologies Inc   258.01 %
Elite Pharmaceuticals Inc   240.11 %
Gadsden Properties, Inc.  222.54 %

Date modified: 2026-08-31T14:06:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.